Perspective Therapeutics Inc. (CATX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Perspective Therapeutics ...

    AMEX: CATX · Real-Time Price · USD
    3.30
    -0.08 (-2.37%)
    At close: Aug 29, 2025, 10:45 AM

    Perspective Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Jun 30, 2022
    PE Ratio
    		 -2.59 -4.75 -9.24 -23.72
    PEG Ratio
    		 -0.06 -0.02 -0.09 -0.19
    PS Ratio
    		 n/a 153.92 19.09 15.72
    PB Ratio
    		 0.71 2.94 2.48 2.77
    P/FCF Ratio
    		 -2.83 -5.81 -10.87 -21.27
    P/OCF Ratio
    		 -11.23 -5.98 -11.14 -22
    OCF/S Ratio
    		 n/a -25.74 -1.71 -0.71
    Debt / Equity Ratio
    		 0.01 0.03 n/a 0.01
    Quick Ratio
    		 12.68 1.07 19.36 25.57
    Current Ratio
    		 12.68 1.07 19.89 26.18
    Asset Turnover
    		 n/a 0.01 0.12 0.17
    Interest Coverage
    		 -217.9 -487.39 n/a -62.11
    Return on Equity
    		 -0.27 -0.62 -0.27 -0.12
    Return on Assets
    		 -0.23 -0.48 -0.25 -0.11
    Return on Invested Capital
    		 0.03 -0.46 -0.29 -0.12
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 0.23 0.43
    Net Profit Margin
    		 n/a -32.43 -2.07 -0.66
    Pretax Profit Margin
    		 n/a -27.97 -2.07 -0.67
    Operating Profit Margin
    		 n/a -28.55 -2.14 -0.68
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a -27.87 -2.09 -0.68

    Add to Watchlist